PER 1.23% 8.0¢ percheron therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-44

  1. 2,954 Posts.
    lightbulb Created with Sketch. 484
    As previously posted on a few occasions from the Quarterly Ann. -

    "The samples were then processed under a two-part analysis: functional (effect on muscle) and cellular (RNA and protein levels). Functional analysis results are due imminently with the cellular analysis to follow next month. Any applicable patent filings would be made ahead of disclosure of the results."

    A Trading Halt would be most welcomed tomorrow - fingers crossed...lol!

    GLTAH$$$$
    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.